Related Experiment Video
Updated: Sep 17, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Imaging cancer metabolism using magnetic resonance
1Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. kmb1001@cam.ac.uk.
Abstract:
The challenge in clinical oncology is to select the most appropriate treatment for an individual patient. Transcriptome and metabolite profiling have revealed that tumours can display metabolic subtypes with different therapeutic vulnerabilities1-4. Metabolic imaging has the potential to distinguish these subtypes and therefore those treatment(s) that should be most effective. Moreover, since changes in tumour metabolism can occur early during treatment, metabolic imaging can also be used subsequently to detect early evidence of treatment response. In this Perspective I briefly review and discuss the relative advantages and disadvantages of magnetic resonance imaging of tumour metabolism using hyperpolarized 13C- and 2H-labelled substrates.
Insights
Metabolic imaging using hyperpolarized carbon-13 and deuterium-2H substrates can identify distinct tumor metabolic subtypes. This approach aids in selecting personalized cancer treatments and monitoring early treatment response.
Area of Science:
- Oncology
- Medical Imaging
- Metabolic Profiling
Background:
- Selecting optimal cancer treatments for individual patients is a significant clinical challenge.
- Tumor metabolic subtypes, identified through transcriptome and metabolite profiling, exhibit varying therapeutic vulnerabilities.
- Metabolic imaging offers a potential method to differentiate these subtypes and guide treatment selection.
Purpose of the Study:
- To review the advantages and disadvantages of using magnetic resonance imaging (MRI) with hyperpolarized 13C- and 2H-labelled substrates for assessing tumor metabolism.
- To discuss the role of metabolic imaging in identifying tumor subtypes and predicting treatment effectiveness.
- To explore the utility of metabolic imaging in detecting early treatment response.
Main Methods:
- Review of magnetic resonance imaging (MRI) techniques.
- Discussion of hyperpolarized 13C-labelled substrates.
- Discussion of hyperpolarized 2H-labelled substrates.
Main Results:
- Metabolic imaging can distinguish tumors based on their metabolic profiles, suggesting different therapeutic vulnerabilities.
- Early metabolic changes during treatment can be detected using metabolic imaging, indicating treatment response.
- Hyperpolarized 13C and 2H MRI offer distinct advantages and disadvantages for metabolic assessment.
Conclusions:
- Metabolic imaging holds promise for personalized oncology by enabling the selection of tailored treatments based on tumor metabolic subtypes.
- This imaging modality can also serve as an early indicator of treatment efficacy.
- Further research into hyperpolarized MRI techniques is warranted to optimize their clinical application in cancer management.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

